| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Pharmaceutical Sciences State University of New York (SUNY) at Buffalo, Buffalo, New York
2 Department of Biological Sciences, State University of New York (SUNY) at Buffalo, Buffalo, New York
3 Children's National Medical Center, Washington, District of Columbia
The transcriptional response of skeletal muscle to chronic corticosteroid exposure was examined over 168 h and compared with the response profiles observed following a single dose of corticosteroid. Male adrenalectomized Wistar rats were given a constant-rate infusion of 0.3 mg·kg–1·h–1 methylprednisolone for up to 7 days via subcutaneously implanted minipumps. Four control and forty drug-treated animals were killed at ten different time points during infusion. Liver total RNAs were hybridized to 44 individual Affymetrix REA230A gene chips. Previously, we described a filtration approach for identifying genes of interest in microarray data sets developed from tissues of rats treated with methylprednisolone (MPL) following acute dosing. Here, a similar approach involving a series of three filters was applied sequentially to identify genes of interest. These filters were designed to eliminate probe sets that were not expressed in the tissue, not regulated by the drug, or did not meet defined quality control standards. Filtering eliminated 86% of probe sets, leaving a remainder of 2,316 for further consideration. In a previous study, 653 probe sets were identified as MPL regulated following administration of a single (acute) dose of the drug. Comparison of the two data sets yielded 196 genes identified as regulated by MPL in both dosing regimens. Because of receptor downregulation, it was predicted that genes regulated by receptor-glucocorticoid response element interactions would exhibit tolerance in chronic profiles. However, many genes did not exhibit steroid tolerance, indicating that present perspectives on the mechanism of glucocorticoid action cannot entirely explain all temporal profiles.
glucocorticoids; corticosteroids; Affymetrix gene chips; gene expression; time series
This article has been cited by other articles:
|
|
 |
|
  N. Yoshikawa, M. Nagasaki, M. Sano, S. Tokudome, K. Ueno, N. Shimizu, S. Imoto, S. Miyano, M. Suematsu, K. Fukuda, et al. Ligand-based gene expression profiling reveals novel roles of glucocorticoid receptor in cardiac metabolism Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1363 - E1373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R Almon, D. C DuBois, W. Lai, B. Xue, J. Nie, and W. J Jusko Gene expression analysis of hepatic roles in cause and development of diabetes in Goto-Kakizaki rats J. Endocrinol., March 1, 2009; 200(3): 331 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Wu, S. Ghimbovschi, P. K. Aujla, M. C. Rose, and M. T. Pena Expression Profiling of Inflammatory Mediators in Pediatric Sinus Mucosa Arch Otolaryngol Head Neck Surg, January 1, 2009; 135(1): 65 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Waddell, L. M. Baehr, J. van den Brandt, S. A. Johnsen, H. M. Reichardt, J. D. Furlow, and S. C. Bodine The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E785 - E797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Almon, E. Yang, W. Lai, I. P. Androulakis, S. Ghimbovschi, E. P. Hoffman, W. J. Jusko, and D. C. DuBois Relationships between circadian rhythms and modulation of gene expression by glucocorticoids in skeletal muscle Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2008; 295(4): R1031 - R1047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O Schakman, H Gilson, and J P Thissen Mechanisms of glucocorticoid-induced myopathy J. Endocrinol., April 1, 2008; 197(1): 1 - 10. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
